Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
33%
Ph phase_1
1
33%
Ph phase_2
1
33%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Completed(1)

Detailed Status

Not yet recruiting2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (33.3%)
Phase 21 (33.3%)
N/A1 (33.3%)

Trials by Status

completed133%
not_yet_recruiting267%

Recent Activity

0 active trials
Showing 3 of 3
not_yet_recruitingnot_applicable

Diacerein in the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease

NCT07199933
completedphase_2

Efficacy of Diacerein Supplementation on Interleukin-1β, Hs-CRP, TNF-α Levels and Glycemic Control in Uncontrolled Type 2 Diabetes Mellitus Patients at Dr. Mohammad Hoesin General Hospital Palembang

NCT06912035
not_yet_recruitingphase_1

Bioequivalence Study of Diacerein 50 mg Capsule in Healthy Thai Volunteers

NCT06308068

Clinical Trials (3)

Showing 3 of 3 trials
NCT07199933Not Applicable

Diacerein in the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease

Not Yet Recruiting
NCT06912035Phase 2

Efficacy of Diacerein Supplementation on Interleukin-1β, Hs-CRP, TNF-α Levels and Glycemic Control in Uncontrolled Type 2 Diabetes Mellitus Patients at Dr. Mohammad Hoesin General Hospital Palembang

Completed
NCT06308068Phase 1

Bioequivalence Study of Diacerein 50 mg Capsule in Healthy Thai Volunteers

Not Yet Recruiting

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3